83 related articles for article (PubMed ID: 31642198)
1. Identification of susceptibility gene mutations associated with the pathogenesis of familial nonmedullary thyroid cancer.
Zhu J; Wu K; Lin Z; Bai S; Wu J; Li P; Xue H; Du J; Shen B; Wang H; Liu Y
Mol Genet Genomic Med; 2019 Dec; 7(12):e1015. PubMed ID: 31642198
[TBL] [Abstract][Full Text] [Related]
2. CHEK2 germline variants identified in familial nonmedullary thyroid cancer lead to impaired protein structure and function.
Pires C; Marques IJ; Valério M; Saramago A; Santo PE; Santos S; Silva M; Moura MM; Matos J; Pereira T; Cabrera R; Lousa D; Leite V; Bandeiras TM; Vicente JB; Cavaco BM
J Biol Chem; 2024 Mar; 300(3):105767. PubMed ID: 38367672
[TBL] [Abstract][Full Text] [Related]
3. Genetic Mutations and Variants in the Susceptibility of Familial Non-Medullary Thyroid Cancer.
Miasaki FY; Fuziwara CS; Carvalho GA; Kimura ET
Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33218058
[TBL] [Abstract][Full Text] [Related]
4. Familial nonmedullary thyroid cancer: a case series in Iranian patients with a meta-review of case series.
Mohammadi Zaniani Z; Zeinalian M; Tabatabaiefar MA
Lab Med; 2023 Nov; ():. PubMed ID: 38007399
[TBL] [Abstract][Full Text] [Related]
5. Investigating
Teixeira E; Fernandes C; Bungărdean M; Paula ADC; Lima RT; Batista R; Vinagre J; Sobrinho-Simões M; Máximo V; Soares P
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338801
[TBL] [Abstract][Full Text] [Related]
6. Identification of
Jiang YJ; Xia Y; Hu YX; Han ZJ; Guo AY; Huang T
Thyroid; 2024 Mar; ():. PubMed ID: 38411500
[No Abstract] [Full Text] [Related]
7. Clinical characteristics and prognosis of familial nonmedullary thyroid carcinoma.
de Carlos Artajo J; Irigaray Echarri A; García Torres J; Pineda Arribas JJ; Ernaga Lorea A; Eguílaz Esparza N; Zubiría Gortázar JM; Anda Apiñániz E
Endocrinol Diabetes Nutr (Engl Ed); 2021 Sep; ():. PubMed ID: 34503933
[TBL] [Abstract][Full Text] [Related]
8. Genetics of Familial Non-Medullary Thyroid Carcinoma (FNMTC).
Diquigiovanni C; Bonora E
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33946592
[TBL] [Abstract][Full Text] [Related]
9. Familial Cancer Variant Prioritization Pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer family.
Kumar A; Bandapalli OR; Paramasivam N; Giangiobbe S; Diquigiovanni C; Bonora E; Eils R; Schlesner M; Hemminki K; Försti A
Sci Rep; 2018 Aug; 8(1):11635. PubMed ID: 30072699
[TBL] [Abstract][Full Text] [Related]
10. Identification of potential pathogenic mutations in Chinese children with first branchial cleft anomalies detected by whole-exome sequencing.
Yang Y; Liu W; Jin Y; Chen M; Lu J; Yu Y; Ren H; Han S; Chu P; Guo Y; Zhang J; Ni X
Pediatr Investig; 2021 Sep; 5(3):211-216. PubMed ID: 34589676
[TBL] [Abstract][Full Text] [Related]
11. Identification of
Marques IJ; Gomes I; Pojo M; Pires C; Moura MM; Cabrera R; Santos C; van IJcken WFJ; Teixeira MR; Ramalho JS; Leite V; Cavaco BM
Thyroid; 2021 Sep; 31(9):1366-1375. PubMed ID: 33906393
[No Abstract] [Full Text] [Related]
12. Chromosomal localization of mutated genes in non-syndromic familial thyroid cancer.
Jiang YJ; Xia Y; Han ZJ; Hu YX; Huang T
Front Oncol; 2024; 14():1286426. PubMed ID: 38571492
[TBL] [Abstract][Full Text] [Related]
13. Identification of a Novel Germline
Hu Y; Han Z; Guo H; Zhang N; Shen N; Jiang Y; Huang T
Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38275415
[TBL] [Abstract][Full Text] [Related]
14. Role of microRNA-4739 in enhancing cisplatin chemosensitivity by negative regulation of RHBDD2 in human cervical cancer cells.
Li Y; Zhou Z; Qu J; Gong P; Wei Y; Sun Y
Cell Mol Biol Lett; 2024 Jan; 29(1):20. PubMed ID: 38267862
[TBL] [Abstract][Full Text] [Related]
15. Expression of anoctamin 7 (ANO7) is associated with poor prognosis and mucin 2 (MUC2) in colon adenocarcinoma: a study based on TCGA data.
Chen C; Aluksanasuwan S; Somsuan K
Genomics Inform; 2023 Dec; 21(4):e46. PubMed ID: 38224713
[TBL] [Abstract][Full Text] [Related]
16. Cribriform Morular Thyroid Carcinoma - Ultimobranchial Pouch-Related? Deep Molecular Insights of a Unique Case.
Dettmer MS; Hürlimann S; Scheuble L; Vassella E; Perren A; Wicke C
Endocr Pathol; 2023 Sep; 34(3):342-348. PubMed ID: 37249797
[TBL] [Abstract][Full Text] [Related]
17. Hereditable variants of classical protein tyrosine phosphatase genes: Will they prove innocent or guilty?
Hendriks WJAJ; van Cruchten RTP; Pulido R
Front Cell Dev Biol; 2022; 10():1051311. PubMed ID: 36755664
[TBL] [Abstract][Full Text] [Related]
18. Identification of NID1 as a novel candidate susceptibility gene for familial non-medullary thyroid carcinoma using whole-exome sequencing.
de Mello LEB; Carneiro TNR; Araujo AN; Alves CX; Galante PAF; Buzatto VC; das Graças de Almeida M; Vermeulen-Serpa KM; de Lima Vale SH; José de Pinto Paiva F; Brandão-Neto J; Cerutti JM
Endocr Connect; 2022 Jan; 11(1):. PubMed ID: 34941562
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
